Literature DB >> 16469442

Differential effects of indoleamines on auditory choice reaction, selective attention, and pitch discrimination.

Michael Schwenzer1, Hans-Christian Heitkamp, Klaus Mathiak.   

Abstract

The indoleamines serotonin and melatonin (MT) affected visual processing such as choice reaction. This study determined whether the indoleamines influence the processing of auditory stimuli. Serotonergic activity was increased using citalopram (CIT). We compared effects of single doses of 40 mg CIT, 1 mg MT, and placebo (randomized double-blind, cross-over design) in 18 healthy men. The applied tests assessed auditory choice reaction, selective attention, and serial discrimination using pitch variations as stimuli in each task. CIT reduced the performance in choice reaction and selective attention but not discrimination. MT tended to reduce selective attention and to improve discrimination. The findings suggest that indoleamines had different effects on distinct kinds of auditory processing. Serotonergic activation improved visual choice reaction, whereas the opposite effect was found in the auditory domain. We conclude that disorders and drugs affecting the indoleamines must be considered differentially in the auditory and the visual system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469442     DOI: 10.1016/j.neulet.2006.01.016

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  The bright side of being blue: depression as an adaptation for analyzing complex problems.

Authors:  Paul W Andrews; J Anderson Thomson
Journal:  Psychol Rev       Date:  2009-07       Impact factor: 8.934

2.  Impaired pitch identification as a potential marker for depression.

Authors:  Michael Schwenzer; Eva Zattarin; Michael Grözinger; Klaus Mathiak
Journal:  BMC Psychiatry       Date:  2012-04-19       Impact factor: 3.630

3.  Numeric aspects in pitch identification: an fMRI study.

Authors:  Michael Schwenzer; Klaus Mathiak
Journal:  BMC Neurosci       Date:  2011-03-09       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.